Ivy leaf

EMA Well-Established Use monograph for productive cough; NICE made no recommendation.

Evidence
Preliminary evidenceGRADE certainty: Low
Typical dose
Adults and adolescents: 5–7.5 ml syrup of the studied extract three times daily, or 35 mg dry extract tablets twice daily
Time to effect
Symptom improvement often within 4–7 days
Safety
Has documented cautions

Evidence ratings summarise published research on Ivy leaf in general. They are not a health claim for any product and not advice for any individual. Talk to your doctor before starting anything new, especially if you take medication.

Ask about Ivy leaf

Interactions

Taking any medication?

Check Ivy leaf against it.

Why

Ivy leaf (Hedera helix) extract holds an EMA Well-Established Use monograph for productive cough, the higher regulatory tier requiring bibliographic evidence of clinical efficacy. NICE (2019) found some evidence of reduced cough symptoms but judged the clinical importance unclear, noted a lack of safety data and made no recommendation either way.

How it works

Saponins (hederagenin, α-hederin) reduce bronchial mucus viscosity and stimulate β2-adrenoceptor signalling in airway smooth muscle, producing mild bronchodilation and mucolytic effect without the dry-cough adverse effect of suppressants.

Expected onset · Symptom improvement often within 4–7 days

How to take

Dosage

Adults and adolescents: 5–7.5 ml syrup of the studied extract (EA 575) three times daily, or 35 mg dry extract tablets twice daily. Children's doses follow the product label and its age limits.

Timing

Three times daily during symptomatic phase

On the label

The trials used the extract EA 575; otherwise look for extracts standardised to '5–7.5:1 ethanol extract' or with stated hederacoside C content. Generic ivy syrups vary widely.

Studied in

Adults and adolescents with productive cough; use in children follows the age limits on the product label.

Safety

The EMA monograph contraindicates ivy leaf in children under 2 years (risk of worsening breathing symptoms) and does not recommend it at 2–4 years. Persistent cough, fever, breathlessness or coughing up blood need medical assessment. Mild GI upset and rare allergic skin reactions. Some liquid preparations contain sorbitol, relevant in fructose intolerance. Pregnancy and breastfeeding data are limited.
Loading interactions…

Evidence

At a glance

EMA herbal monograph (well-established use) recognises ivy leaf extract for productive cough, based on bibliographic clinical evidence. NICE (2019) reviewed ivy, primrose and thyme herbal products for acute cough and found some evidence of reduced symptoms, but judged the clinical importance unclear and safety data lacking, so it made no recommendation.

GRADE certainty: Low — EMA well-established use monograph (bibliographic evidence); NICE 2019 judged clinical significance unclear

Questions people ask

Does Ivy leaf work?

EMA herbal monograph (well-established use) recognises ivy leaf extract for productive cough, based on bibliographic clinical evidence. NICE (2019) reviewed ivy, primrose and thyme herbal products for acute cough and found some evidence of reduced symptoms, but judged the clinical importance unclear and safety data lacking, so it made no recommendation. Certainty of the evidence: Low, EMA well-established use monograph (bibliographic evidence); NICE 2019 judged clinical significance unclear.

How is Ivy leaf taken?

Adults and adolescents: 5–7.5 ml syrup of the studied extract (EA 575) three times daily, or 35 mg dry extract tablets twice daily. Children's doses follow the product label and its age limits. Timing: Three times daily during symptomatic phase. Ranges are those reported in the cited sources, not individual advice; talk to your doctor or pharmacist before starting, especially if you take medication.

Are there interactions or cautions?

The EMA monograph contraindicates ivy leaf in children under 2 years (risk of worsening breathing symptoms) and does not recommend it at 2–4 years. Persistent cough, fever, breathlessness or coughing up blood need medical assessment. Mild GI upset and rare allergic skin reactions. Some liquid preparations contain sorbitol, relevant in fructose intolerance. Pregnancy and breastfeeding data are limited. Documented drug and supplement interactions can be looked up in the free interaction reference.

What is the evidence based on?

Sources: EMA HMPC monograph, Hedera helix L., folium (Well-Established Use + Traditional Use); NICE guideline (2019): Cough (acute): antimicrobial prescribing – NG120 (Summary of the Evidence).

One evidence finding a day, like this one: follow Healicus on Threads or Bluesky.